We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.40
Bid: 68.40
Ask: 68.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.292%)
Open: 68.60
High: 68.80
Low: 68.40
Prev. Close: 68.40
AXB Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disclosure under Reg 30 of SEBI (LODR) Regulations

9 Aug 2023 13:45

RNS Number : 8350I
Axis Bank Limited
09 August 2023
 

 AXIS/CO/CS/253/2023-24

 

 August 9, 2023

 

 Dear Sir(s),

 

 Sub: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

 

This is with reference to our earlier letters dated April 28, 2020, July 23, 2020, August 24, 2020, October 30, 2020, February 24, 2021, April 6, 2021 and January 10, 2023, informing that Axis Bank Limited ("Axis Bank") and its subsidiaries, i.e., Axis Securities Limited and Axis Capital Limited (together referred to as "Axis Entities") have entered into agreements (including amendments thereto) with Max Financial Services Limited ("Max Financial"), with regard to acquisition of equity stake of Max Life Insurance Company Limited ("Max Life") and matters incidental thereto.

 

In this regard, we would now like to inform you that the Acquisitions, Divestments and Merger Committee of the Board of Directors of the Bank at their meeting held on August 9, 2023 has approved the proposal for the Axis Bank to infuse Rs. 1,612 crores in Max Life through preferential allotment, resulting in Axis Bank's direct stake in Max Life increasing to 16.22% and the collective stake of Axis Entities increasing to 19.02%.

 

As communicated vide our letter dated January 10, 2023, the aforesaid acquisition would be done at Fair Market Value using Discounted Cash Flow method. The Bank will now enter into a Share Subscription Agreement with Max Life for proposed acquisition through subscription to the Preferential Issue of 14,25,79,161 fully paid-up equity shares of face value of Rs. 10 each, at a fair market value of Rs. 113.06 per share (arrived at as per extant regulations and including a share premium of Rs. 103.06 per equity share).

 

The transaction is subject to regulatory approvals, including IRDAI, PFRDA, CCI and any other requisite approval. The Bank has requisite approval from the Reserve Bank of India for the proposed acquisition.

 

A detailed disclosure as required under SEBI Circular dated July 13, 2023, is attached as Annexure A.

http://www.rns-pdf.londonstockexchange.com/rns/8350I_1-2023-8-9.pdf

 

The meeting commenced at 5.15 P.M. and concluded at 5.35 P.M.

 

This is for your information and records.

 

Thanking you,

 

Yours Sincerely,

For Axis Bank Limited

 

 

 

Sandeep Poddar

Company Secretary

 

CC: London Stock Exchange

Singapore Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSEFEUEDSELA
Date   Source Headline
25th Apr 20241:41 pmRNSOutcome of Board Meeting
25th Apr 20247:43 amRNSGrant of Stock Options/Units
25th Apr 20247:38 amRNSRe-appointment of Directors
24th Apr 202412:52 pmRNSOutcome of Board Meeting
24th Apr 202412:45 pmRNSFinancial Results
19th Apr 202410:39 amRNSAppointment of Joint Statutory Auditors
18th Apr 20242:39 pmRNSBoard Meeting Intimation
18th Apr 20247:00 amRNSUpdate on Acquisition
10th Apr 20249:49 amRNSPostal Ballot Notice dated April 4, 2024
3rd Apr 202412:09 pmRNSUpdate on Acquisition
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:53 amRNSRevision in Vesting Period - ESOS
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
15th Dec 20238:36 amRNSCessation
1st Dec 20231:52 pmRNSPostal Ballot Results
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
22nd Nov 20232:22 pmRNSCredit Rating
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
1st Nov 20238:36 amRNSPostal Ballot Notice
26th Oct 20232:46 pmRNSPostal Ballot Voting Results
26th Oct 20231:35 pmRNSCessation
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
3rd Oct 20239:54 amRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
18th Aug 202311:17 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
28th Jul 20233:47 pmRNSVoting Results AGM
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.